CD4 and plasma cell myeloma: Chemotherapy aggravates the immunodeficient state of myeloma patients, resulting in significant reductions in CD4+ as well as specific reductions in CD4+ CD45RO+ cells as compared to untreated myeloma; this decrease is strongly associated with opportunistic infections (25).